• LOGIN
  • CONTACT US
  • enEnglish (English)
    • deDeutsch (German)
    • esEspañol (Spanish)
    • zh-hans简体中文 (Chinese (Simplified))
    • ja日本語 (Japanese)
    • pt-brPortuguês (Portuguese (Brazil))
    • heעברית (Hebrew)
    • ko한국어 (Korean)
    • frFrançais (French)
Arazy Group Consultants Inc.
  • Regulatory Solutions
    • LICENSALE®
    • REGISLATE®
    • Choose Your Regulatory Solution
    • Cost and Savings
    • European Regulatory Representative Services
  • 140 Countries
  • Resources
  • About Us
    • Webinars
    • Careers
Select Page

Changes to the Implementation of IVDR

by arazygroup | Oct 20, 2021 | Blog, Regulatory News Slider | 0 comments

By Fajar Dumadi | October 20, 2021

According to the Regulation (EU) 2017/746 (IVDR) (1) the industry was given until 26 May 2022 to fully implement the regulation; it is required to have the product CE marked by the stipulated deadline.

However, according to the market surveys conducted in 2021 by notified bodies and the trade association MedTech Europe, there are over 24,000 IVDs that will require the involvement of a notified body. From the 520 certification applications received by notified bodies (this covers roughly 9,600 devices) 95% certificates are yet to be issued. Currently, there are only 6 notified bodies designated. Although the EU authorities insisted that there will be no delay for IVDR, the slow pace of notified bodies designation has proven otherwise.

In October 2021, a proposal to amend the Regulation (EU) 2017/746 (IVDR) was approved (2). Under this proposal, the following amendments are proposed:

1. Certificates issued in accordance with Annex VI to Directive 98/79/EC shall become void by May 27, 2025.

2. Certificates issued by notified bodies in accordance with Directive 98/79/EC from May 25, 2017 shall become void by May 27, 2025.

3. Devices for which the conformity assessment procedure pursuant to Directive 98/79/EC did not require the involvement of a notified body, a declaration of conformity was drawn up prior to May 26, 2022 in accordance with that directive, and for which the conformity assessment procedure pursuant to this regulation requires the involvement of a notified body, may be placed on the market or put into service until the following dates:

  • 26 May 2025 for class D devices
  • 26 May 2026 for class C devices 
  • 26 May 2027 for class B devices  
  • 26 May 2027 for class A devices placed on the market in sterile condition.

4. Devices lawfully placed on the market pursuant to Directive 98/79/EC prior to May 26, 2022 may continue to be made available on the market or put into service until May 26, 2025.

However, these amendments will only benefit devices that require a notified body certificate under Directive 98/79/EC. The transitional period is differentiated between risk classes to balance the notified body capacity with high level of public health protection.

On the other hand, The IVDR is not postponed and the general application date of the regulation remains May 26, 2022, especially for CE marked in-vitro diagnostic medical devices that do not require the involvement of a notified body (i.e. class A non-sterile devices which represent around 20% of the market) and for ‘new’ in-vitro diagnostics (i.e. those not covered by a certificate or a manufacturer’s declaration of conformity issued prior to 26 May 2022).

 

 

References
  1. The European Parliament and The Council of The European Union. EUR-Lex – 02017R0746-20170505 – EN. EUR-Lex (Access to European Union Law). [Online] May 5, 2017. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A02017R0746-20170505.
  2.  EUR-Lex – 52021PC0627 – EN. EUR-Lex – Access to European Union Law. [Online] October 14, 2021. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A52021PC0627.

 

 

 

 

Contact Us!

Arazy Group has over 25 years of regulatory expertise in medical devices and IVD devices.

Contact us at [email protected] for any inquiries or regulatory assistance. 

D

Search

Recent Posts

  • Malaysia – July 2022
  • Pakistan – July 2022
  • South Africa – June 2022
  • La Technologie des Dispositifs Médicaux
  • The Philippines- June 2022
  • Singapore- April 2022
  • Indonesia- March 2022
  • Malaysia- march 2022
  • The Philippines- Feb 2022
  • Malaysia Update – January 2022

Recent Comments

    Archives

    Categories

    • Application
    • Blog
    • Case Study
    • Documents
    • Homepage
    • Product Demo
    • Product Demo Slider
    • Products
    • Recent Registrations
    • Regulatory News
    • Regulatory News Slider
    • Regulatory Update
    • Regulatory Update Slider
    • Support
    • Top Story Slider
    • Uncategorized
    • Videos

    Arazy Group Consultants Inc. is an international consultancy spanning several continents, assisting medical and IVD device companies with regulatory compliance and affairs as they try to enter new markets

    Visit Us On FacebookVisit Us On TwitterVisit Us On Linkedin

    Regulatory Solutions

    • LICENSALE
    • REGISLATE
    • European Regulatory Representative Services
    • Resources
    • Privacy Policy
    • ISO 9001 Certificate

    Head Office

    #200-1333 Johnston St., Granville Island,
    Vancouver, BC V6H 3R9

    PHONE: +1 604.681.6888
    FAX: +1 604.681.6822
    [email protected]

    © Arazy Group Consultants Inc. - is an international consultancy spanning several continents, assisting medical and IVD device companies with regulatory compliance and affairs as they try to enter new markets
    ???

    We are using cookies to give you the best experience on our website.

    You can find out more about which cookies we are using or switch them off in settings.

    Arazy Group Consultants Inc.
    Powered by  GDPR Cookie Compliance
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

    Strictly Necessary Cookies

    Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

    If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

    Security_overview - Privacy Policy